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Nicotinamide phosphoribosyltransferase (NAMPT),
the key NAD+ biosynthetic enzyme, has two different
forms, intra- and extracellular (iNAMPT and
eNAMPT), in mammals. However, the significance
of eNAMPT secretion remains unclear. Here we
demonstrate that deacetylation of iNAMPT by the
mammalian NAD+-dependent deacetylase SIRT1
predisposes the protein to secretion in adipocytes.
NAMPT mutants reveal that SIRT1 deacetylates
lysine 53 (K53) and enhances eNAMPT activity and
secretion. Adipose tissue-specific Nampt knockout
and knockin (ANKO and ANKI) mice show reciprocal
changes in circulating eNAMPT, affecting hypotha-
lamic NAD+/SIRT1 signaling and physical activity
accordingly. The defect in physical activity observed
in ANKO mice is ameliorated by nicotinamide mono-
nucleotide (NMN). Furthermore, administration of a
NAMPT-neutralizing antibody decreases hypotha-
lamic NAD+ production, and treating ex vivo hypo-
thalamic explants with purified eNAMPT enhances
NAD+, SIRT1 activity, and neural activation. Thus,
our findings indicate a critical role of adipose tissue
as a modulator for the regulation of NAD+ biosyn-
thesis at a systemic level.
INTRODUCTION
The biosynthesis of nicotinamide adenine dinucleotide (NAD+),
an essential coenzyme and important currency for cellular
energy metabolism, plays a critical role in the regulation of
diverse biological processes through key NAD+-consuming
mediators, including poly-ADP-ribose polymerases (PARPs),
CD38/157 ectoenzymes, and sirtuins (Stein and Imai, 2012).
NAD+ can be synthesized from four different substrates: nicotin-
amide, nicotinic acid, tryptophan, and nicotinamide riboside706 Cell Metabolism 21, 706–717, May 5, 2015 ª2015 Elsevier Inc.(NR) (Houtkooper et al., 2010; Imai and Guarente, 2014). Among
them, nicotinamide is predominantly used to synthesize NAD+ in
mammals (Stein and Imai, 2012). Starting from nicotinamide,
NAD+ biosynthesis is catalyzed by two key enzymes: nicotin-
amide phosphoribosyltransferase (NAMPT) and nicotinamide
mononucleotide adenylyltransferase (NMNAT) (Garten et al.,
2009; Imai, 2009; Imai and Guarente, 2014). NAMPT, the rate-
limiting enzyme in this NAD+ biosynthetic pathway, catalyzes
the conversion of nicotinamide and 50-phosphoribosyl-pyro-
phosphate (PRPP) to nicotinamide mononucleotide (NMN), a
key NAD+ intermediate. NMN, in turn, is adenylated by NMNAT
to generate NAD+.
NAMPT is a unique enzyme that has an ancient origin and an
interesting research history (Garten et al., 2009; Imai, 2009).
NAMPT was originally identified as the product of the gene
that confers the capability of synthesizing NAD+ from nicotin-
amide, called NadV, in Haemophilus ducreyi (Martin et al.,
2001). Surprisingly, a set of genes encoding NAMPT andNMNAT
homologs has even been found in some bacteriophages (Miller
et al., 2003). The biochemical and structural features of NAMPT
have been extensively studied by our and other groups, clearly
demonstrating that this protein belongs to a dimeric class of
type II phosphoribosyltransferases (Khan et al., 2006; Revollo
et al., 2004; Rongvaux et al., 2002; Wang et al., 2006). Interest-
ingly, NAMPT has two different forms in mammals: intra- and
extracellular NAMPT (iNAMPT and eNAMPT, respectively) (Re-
vollo et al., 2007). eNAMPT was previously identified as pre-B
cell colony-enhancing factor (PBEF), a presumptive cytokine
that enhanced the maturation of B cell precursors, and as visfa-
tin, a visceral fat-derived adipokine once proposed to exert an
insulin-mimetic function by binding to the insulin receptor (Fuku-
hara et al., 2005, 2007; Garten et al., 2009; Imai, 2009; Samal
et al., 1994). Neither function of PBEF nor visfatin has been re-
confirmed to date. Our previous study has clearly demonstrated
that NAMPT functions as an intra- and extracellular NAD+
biosynthetic enzyme and that eNAMPT does not exert insulin-
mimetic effects, either in vitro or in vivo (Revollo et al., 2007).
However, the physiological relevance and function of eNAMPT
has still been controversial, and whether eNAMPT secretion is
actively regulated has been of significant debate. Here we
Figure 1. iNAMPT Acetylation Levels
Decrease in Response to Fasting in Adipose
Tissue and Are Associated with eNAMPT
Secretion in Differentiated Adipocytes
(A) iNAMPT acetylation levels in brown and white
adipose tissues (BAT and WAT) of fed and fasted
wild-type female mice at 4–5 months of age. The
right panel represents average values from two
independent experiments. Relative iNAMPT acet-
ylation levels are normalized to fed values.
(B) iNAMPT acetylation levels in differentiated HIB-
1B cells. Cells were treated with 5 mM Trichostatin
A (T) and 5 mM nicotinamide (N) for 3 hr. M, mock
treatment.
(C) Reduction of eNAMPT secretion after Trichos-
tatin A (T) and nicotinamide (N) treatment in
differentiated HIB-1B cells. Levels of eNAMPT
secretion were calculated as described in Experi-
mental Procedures.
(D) Enhancement of eNAMPT secretion in
response to low glucose in differentiated HIB-1B
cells and 3T3-L1 cells. Cells were incubated with
high-glucose (H, 25 mM) or low-glucose (L, 5 mM)
media in the presence or absence of nicotinamide
(N, 5 mM) for 3 hr. Bottom panels in (C) and (D)
represent average values of three independent
experiments. Each value is normalized to values
from the mock (C) or the high-glucose condition
(D). Data were analyzed by the Student’s t test or
one-way ANOVA with Fisher’s LSD post hoc test.
All values are presented as mean ± SEM. *p %
0.05; **p% 0.01; ***p% 0.001.demonstrate that eNAMPT secretion is regulated by SIRT1-
mediated deacetylation in adipose tissue and also that eNAMPT
secreted by adipose tissue plays an important role in themainte-
nance of hypothalamic NAD+ production and its function in vivo.
RESULTS
Acetylation Levels of iNAMPT Affect the Secretion of
eNAMPT
Fully differentiated brown and white adipocytes secrete
eNAMPT, which has 2- to 4-fold higher enzymatic activity than
iNAMPT (Revollo et al., 2007). We speculated that a post-trans-
lational modification was likely responsible for this altered enzy-
matic activity and the secretion of eNAMPT. Analysis of its
post-translational modification, including acetylation and ADP-
ribosylation, revealed that iNAMPT was acetylated in brown
and white adipose tissue (BAT and WAT, respectively) (Fig-
ure 1A). Interestingly, acetylation levels of iNAMPT decreased
by 50% in response to 48 hr fasting (Figure 1A). To further
assess the effect of NAMPT acetylation on its function and
secretion, we examined differentiated HIB-1B brown adipo-
cytes, which express a very high level of iNAMPT and secrete
eNAMPT into culture supernatants (Revollo et al., 2007). In their
cell extracts, relatively low levels of acetylated iNAMPT were
detected (Figure 1B, lane M). Acetylation levels significantly
increased when treating cells with trichostatin A (TSA) and nico-
tinamide, inhibitors of class I and II deacetylases and class III
NAD+-dependent deacetylases, respectively (Figure 1B, right
two T+N lanes). In this condition, iNAMPT protein levels did not
change in cell extracts, whereas secreted eNAMPT proteinClevels in culture supernatants decreased by 60% (Figure 1C),
implicating that the acetylation status of iNAMPT might predis-
pose the protein to secretion. Because fasting decreased
acetylation levels of iNAMPT in adipose tissue, we examined
the effects of low glucose in media on iNAMPT acetylation and
eNAMPT secretion in HIB-1B cells. Detection of changes in
iNAMPT acetylation turned out to be technically difficult due to
low basal levels of acetylated iNAMPT in HIB-1B cells. Nonethe-
less, lowering glucose dramatically enhanced eNAMPT secre-
tion 3.5- to 5.5-fold in differentiated HIB-1B cells and 3T3-L1
white adipocytes (Figure 1D). Furthermore, nicotinamide com-
pletely inhibited the enhancement of eNAMPT secretion by low
glucose (Figure 1D), suggesting that nicotinamide-sensitive sir-
tuin family members might be responsible for low-glucose-
induced enhancement of eNAMPT secretion.
SIRT1 Regulates eNAMPT Secretion by Physically
Interacting with and Deacetylating iNAMPT
SIRT1 enzymatic activity is effectively inhibited by nicotinamide
in culture conditions (Bitterman et al., 2002). Therefore, we sus-
pected that SIRT1 might regulate eNAMPT secretion in adipose
tissue. To address this possibility, we first examined whole-body
Sirt1 knockout (Sirt1/) mice on an FVB background. Different
from other Sirt1/ mouse lines on the B6 or 129 backgrounds,
these FVB Sirt1/ mice do not die postnatally and can grow
into adulthood (Satoh et al., 2010). In Sirt1+/+ mice, plasma
eNAMPT levels showed moderate but significant increases in
response to 48 hr fasting (Figure 2A). However, these increases
were completely abrogated in Sirt1/ mice (Figure 2A). Intrigu-
ingly, iNAMPT significantly accumulated in the WAT of Sirt1/ell Metabolism 21, 706–717, May 5, 2015 ª2015 Elsevier Inc. 707
Figure 2. Plasma eNAMPT Levels Increase
in Response to Fasting in a SIRT1-Depen-
dent Manner
(A) Plasma eNAMPT levels from fed or 48 hr-fasted
Sirt1+/+ and Sirt1/ male mice at 4–5 months of
age (n = 7–12). The bottom panel shows average
plasma eNAMPT levels normalized to the fed
Sirt1+/+ level in each condition.
(B) iNAMPT and SIRT1 protein levels in white adi-
pose tissue (WAT) and the liver of Sirt1+/+ and
Sirt1/ male mice at 3–4 months of age. iNAMPT
levels are normalized to TUBULIN levels. The right
panel shows average values normalized to the fed
value in each tissue (n = 3).
(C) Nampt mRNA expression levels in WAT of
Sirt1+/+ and Sirt1/ male mice at 3–4 months of
age (n = 4).
(D) Plasma eNAMPT levels from fed or 48 hr-fasted
AT-Sirt1+/+ and AT-Sirt1/ female mice at
6 months of age (n = 5). Data were analyzed by the
Student’s t test or one-way ANOVA with the
Fisher’s LSD post hoc test. All values are pre-
sented as mean ± SEM. *p% 0.05; ***p% 0.001.mice compared to Sirt1+/+ mice, whereas the iNAMPT protein
levels did not differ in the liver between Sirt1+/+ and Sirt1/
mice (Figure 2B). Given that Nampt mRNA levels were indistin-
guishable inWAT between Sirt1+/+ and Sirt1/mice (Figure 2C),
this abnormal accumulation of iNAMPT in Sirt1/ WAT is likely
associated with a defect in eNAMPT secretion in Sirt1/ mice.
To further demonstrate the importance of adipose SIRT1 for
the control of eNAMPT secretion, we generated adipose tis-
sue-specific Sirt1 knockout (AT-Sirt1/) mice. AT-Sirt1/
mice showed a similar phenotype to the whole-body Sirt1/
mice (Figure 2D). Indeed, AT-Sirt1/ mice completely failed to
increase plasma eNAMPT in response to 48 hr fasting, confirm-
ing the physiological relevance of this SIRT1-mediated eNAMPT
secretion from adipose tissue, particularly in response to fasting.
To further examine the role of SIRT1 in eNAMPT secretion, we
overexpressed Sirt1 or Gfp in differentiated HIB-1B adipocytes708 Cell Metabolism 21, 706–717, May 5, 2015 ª2015 Elsevier Inc.by adenoviral transduction and quantified
eNAMPT secretion. Overexpression of
SIRT1 enhanced eNAMPT secretion 2.3-
fold compared to GFP controls in differ-
entiated HIB-1B cells (Figure 3A). We
further confirmed this result by intro-
ducing both NAMPT and SIRT1 into
HEK293 cells, which shows negligible
basal expression of both proteins. Again,
overexpression of SIRT1 enhanced
eNAMPT secretion, and the enhancement
was much more robust in the HEK293
cells (11-fold) compared to that in the
differentiated HIB-1B cells (Figure 3B).
We also assessed the acetylation status
of iNAMPT in this condition. Acetylated
iNAMPT was detected only in the pres-
ence of TSA and nicotinamide, and
iNAMPT acetylation levels significantly
decreased by SIRT1 overexpression (Fig-ure 3C). These results, in combination with the results from
Sirt1/ and AT-Sirt1/mice, suggest that SIRT1-mediated de-
acetylation of iNAMPT predisposes the protein to secretion from
differentiated adipocytes.
Because SIRT1 typically interacts directly with its deacetyla-
tion targets, we also examined whether SIRT1 and iNAMPT
physically interact in differentiated adipocytes. Indeed, SIRT1
and iNAMPT did interact in differentiated HIB-1B adipocytes
(Figure 3D), and this interaction appeared to be enhanced by
low glucose (Figure 3D, right two lanes). Although SIRT1 is
usually considered to be a nuclear sirtuin, we found that a
considerable amount of SIRT1 was localized in the cytoplasm
of differentiated HIB-1B and 3T3-L1 cells (Figures 3E and S1).
iNAMPT was primarily localized in the cytoplasm of these adipo-
cytes (Figures 3E and S1). Therefore, these results suggest that
SIRT1 physically interacts with and deacetylates iNAMPT in the
Figure 3. SIRT1 Promotes eNAMPT Secre-
tion by Deacetylating iNAMPT
(A and B) SIRT1 overexpression promotes
eNAMPT secretion in differentiated HIB-1B cells
(A) and HEK293 cells (B). Levels of eNAMPT
secretion were calculated as described in Experi-
mental Procedures. The right panels represent
average values from three independent experi-
ments. Each value is normalized to those of GFP-
or NAMPT-expressing cells.
(C) SIRT1 overexpression decreases iNAMPT
acetylation levels in HEK293 cells. Cells were
incubated in the absence or presence of 5 mM
Trichostatin A (T) and 5 mM nicotinamide (N)
overnight prior to cell lysis. Acetylated iNAMPT
levels are normalized to total iNAMPT levels. The
right panel represents iNAMPT acetylation levels
normalized to total iNAMPT levels in each condi-
tion (n = 3).
(D) Interaction between SIRT1 and iNAMPT in
differentiated HIB-1B cells.
(E) Subcellular localization of SIRT1 and iNAMPT in
differentiated HIB-1B cells. GAPDH and TBP were
examined as representative cytoplasmic and nu-
clear proteins, respectively. Cells were incubated
with media containing high glucose (H, 25 mM) or
low glucose (L, 5 mM) overnight (D) or for 3 hr (E).
Data were analyzed by the Student’s t test. All
values are presented as mean ± SEM. *p % 0.05;
**p% 0.01; ***p% 0.001.cytoplasm of differentiated adipocytes, promoting the secretion
of eNAMPT.
Deacetylation of K53 on iNAMPT Enhances eNAMPT
Secretion
We next attempted to determine which acetylated residues of
iNAMPT are important for the regulation of eNAMPT secretion.
We established HEK293 and differentiated HIB-1B cells ex-
pressing C-terminally FLAG-tagged iNAMPT, and then FLAG-
tagged iNAMPT and eNAMPT proteins were purified from those
cell extracts and culture supernatants, respectively. These puri-
fied NAMPT proteins, as well as the bacterially produced recom-
binant NAMPT protein, were subjected to a mass spectrometric
analysis of protein modification. Five lysines, K53, K79, K107,
K331, and K369, were found to be acetylated on iNAMPT,
whereas only K369 was acetylated on eNAMPT (Figures 4A
and S2). Surprisingly, 4 out of the 5 lysines were also acetylated
on bacterially produced recombinant NAMPT, although it had
K339 acetylation instead of K107 (Figure 4A). This implies that
regulation of NAMPT acetylation might be conserved from bac-
teria to mammals. Among these acetylated lysines, the locationCell Metabolism 21, 706of K53 on the crystal structure of iNAMPT
is particularly interesting. NAMPT is a
dimeric type II phosphoribosyltrasferase,
and K53, which protrudes from each
monomer, is aligned along the ‘‘cleft’’ of
the dimer and very close to the catalytic
sites (Figure 4B) (Khan et al., 2006;
Wang et al., 2006). Contrarily, K79 is
located at the opposite side of the dimerto K53 (Figure 4B). Other acetylated lysines are located on
surrounding a helices of the dimer. We introduced the deacety-
lation-mimicking K-to-R mutation into K53 and/or K79 and
examined the acetylation levels of each mutant iNAMPT in
response to SIRT1. Whereas the wild-type and K79R mutant
iNAMPT proteins showed SIRT1-dependent deacetylation, the
K53R and K53/79R mutants displayed reduced acetylation
levels and did not show further reduction in acetylation levels
by SIRT1 (Figure 4C), suggesting that K53 is the SIRT1-depen-
dent acetylation site on iNAMPT. We also assessed the enzy-
matic activity and the secretion of this K53R mutant, as well as
another mutant K53A, compared to the wild-type NAMPT in
differentiated HIB-1B adipocytes. The enzymatic activity of
both K53R and K53A mutants did not differ from that of the
wild-type iNAMPT (Figure 4D). However, the secretion of these
mutant proteins was 2.5- to 3-fold higher than that of the wild-
type protein (Figure 4F), strongly suggesting the importance of
this particular lysine and its deacetylation for the regulation of
eNAMPT secretion. Conversely, introduction of the acetylation-
mimicking K-to-Q mutation into K53 significantly decreases the
enzymatic activity and the secretion of the protein (Figures 4E–717, May 5, 2015 ª2015 Elsevier Inc. 709
Figure 4. Deacetylation of K53 on iNAMPT Enhances eNAMPT Secretion and Enzymatic Activity
(A) Acetyl-lysines detected on iNAMPT and eNAMPT prepared from cell lysate of HEK293 cells and culture supernatant of differentiated HIB-1B cells,
respectively. HEK293 cells overexpressing C-terminally FLAG-tagged mouse NAMPT were treated with 5 mM Trichostatin A and 5 mM nicotinamide overnight
prior to cell lysis. FLAG-tagged iNAMPT and eNAMPT were immunopurified and subjected to mass spectrometric analysis. Recombinant mouse NAMPT was
also prepared from bacteria.
(B) The location of K53 and K79 on the crystal structure of dimeric NAMPT (arrows). Eachmonomer is shown in orange or green, and NMNmolecules bound to the
catalytic sites (arrows) are shown in blue.
(C) Changes in the acetylation status of wild-type (WT) or mutant (K53R, K79R, and K53/79R) iNAMPT by SIRT1 in HEK293 cells. Cells were treated with 5 mM
Trichostatin A and 5 mM nicotinamide overnight prior to cell lysis.
(legend continued on next page)
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and 4G), suggesting that acetylation of K53 suppresses NAMPT
enzymatic activity and secretion. Taken together, these results
demonstrate that eNAMPT secretion is regulated by SIRT1
through deacetylation of K53 in differentiated adipocytes.
Adipose Tissue-Specific Nampt Knockout Mice Exhibit
Reduced Plasma eNAMPT Levels and Defects in NAD+
Biosynthesis Not Only in Adipose Tissue, but Also in the
Hypothalamus
Given that the secretion and enzymatic activity of eNAMPT are
highly regulated by SIRT1-dependent deacetylation in differenti-
ated adipocytes, we suspected that eNAMPT secreted by
adipose tissue has a functional role as an extracellular NAD+
biosynthetic enzyme. To address this hypothesis, we generated
adipose tissue-specific Nampt knockout (ANKO) mice by
crossing floxed Nampt (Namptflox/flox) mice (Rongvaux et al.,
2008) and adiponectin-Cre driver mice (Eguchi et al., 2011).
ANKO mice were born following the Mendelian ratio and looked
overtly normal. As expected, ANKO mice showed the complete
lack of iNAMPT expression in visceral WAT and BAT, although
trace amounts of iNAMPT remained in subcutaneous WAT (Fig-
ure 5A). Consistent with the lack of iNAMPT, NAD+ levels were
dramatically reduced to 7%–28% of the control Namptflox/flox
mice in ANKO WAT and BAT (Figure 5B), demonstrating that
NAMPT functions as a major NAD+ biosynthetic enzyme in adi-
pose tissue. This dramatic reduction in NAD+ levels did not
seem to affect the gross structure of white adipose tissue under
an ad libitum-fed condition. Mean white adipocyte diameter,
body weight, and fat mass in ANKO mice were not significantly
different from those in the control Namptflox/flox mice (Figures
S3A–S3C). We found that plasma eNAMPT levels significantly
decreased by 30%–40% in both fed and fasted conditions in
ANKO females, compared to those in control Namptflox/flox
mice (Figure 5C), demonstrating that adipose tissue significantly
contributes to the production of circulating eNAMPT in female
mice. Contrarily, ANKO male mice did not show any detectable
decreases in plasma eNAMPT levels (Figure S3E). Surprisingly,
while other tissues such as the liver and skeletal muscle did
not show any change in NAD+ levels (Figure 5B), the hypothala-
mus, but not the hippocampus, showed significant decreases in
NAD+ levels in ANKO mice compared to controls (Figure 5D).
mRNA expression levels of Nampt and other NAD+ biosynthetic
enzymes showed no decrease in ANKO hypothalami (Fig-
ure S3D), indicating that the reduction in NAD+ levels detected
in ANKO hypothalami was not likely due to intrinsic defects in
their NAD+ biosynthetic machineries. Consistently, mRNA
expression of Ox2r, a SIRT1 target gene in the hypothalamus
(Satoh et al., 2010, 2013), was also significantly decreased in
the hypothalami of ANKO females, but not in their hippocampi
(Figure 5E), indicating that NAD+-dependent SIRT1 activity is
lower in female ANKO hypothalami. Consistent with their plasma
eNAMPT levels, ANKOmales did not show any changes in hypo-
thalamic NAD+ levels (Figure S3F). These results suggest that(D and E) The relative enzymatic activity of wild-type (WT) and mutant iNAMPT
described in Experimental Procedures. Each enzymatic activity is normalized to
(F and G) Secretion of wild-type (WT) andmutant eNAMPT. Levels of eNAMPT sec
normalized to the WT value. Each panel represents averages from three indepen
with the Fisher’s LSD post hoc test. All values are presented as mean ± SEM. *p
Cadipose NAMPT significantly contributes to plasma eNAMPT
and is important to maintain normal NAD+ levels not only in adi-
pose tissue but also in the hypothalamus. Because the results
from AT-Sirt1+/+ and AT-Sirt1/ mice indicate that the SIRT1-
mediated secretion of eNAMPT from adipose tissue is more
important in response to fasting, we examined whether AT-
Sirt1/ mice show any defect in maintaining hypothalamic
NAD+ levels during fasting, compared to their ad libitum-fed con-
dition. We found that hypothalamic NAD+ levels decreased by
20% in response to fasting in control AT-Sirt1+/+ mice, whereas
AT-Sirt1/ mice exhibited further decreases (40%) in hypotha-
lamic NAD+ levels in response to fasting (Figure S3G), supporting
the physiological role of eNAMPT secretion by adipose tissue in
maintaining hypothalamic NAD+ levels.
Physical Activity Is Reciprocally Altered in Loss- and
Gain-of-Function Mouse Models of Adipose NAMPT
In the hypothalamus, SIRT1 regulates Ox2r expression, and this
SIRT1-mediated signaling in the hypothalamus is critical to regu-
late physical activity of mice during the dark time and in response
to fasting (Satoh et al., 2010, 2013; Satoh and Imai, 2014). Given
that levels of NAD+ and Ox2r expression were significantly
reduced in female ANKO hypothalami, we examined their phys-
ical activity during the dark time. Interestingly, we found that fe-
male ANKO mice showed significantly reduced physical activity
during the dark time (Figure 6A), consistent with reduced hypo-
thalamic NAD+ and Ox2r levels, all suggesting the impairment of
SIRT1 activity in the hypothalamus. Because we have previously
demonstrated that systemic administration of NMN can enhance
NAD+ biosynthesis and activate SIRT1 activity in multiple tissues
(Ramseyet al., 2008;Revollo et al., 2007;Yoshino et al., 2011),we
next asked whether NMN administration could rescue the
observed hypothalamic functional defect in ANKO females.
With the dose of NMN that our and other groups have previously
used (500mg/kgbodyweight) (Gomes et al., 2013;Ramsey et al.,
2008;Revollo et al., 2007;Yoshinoet al., 2011),weconfirmed that
each hypothalamic nucleus showed 1.5- to 3.5-fold increases in
NAD+, with a nicely grading distribution of NAD+ from themedian
eminence (Elmquist et al., 1999;Rodrı´guezet al., 2010) toward the
furthest nucleus (Figure S4A). We then injected NMN into ANKO
females at 5 p.m., 1 hr before lights were turned off. Remarkably,
NMN-treatedANKO females showedsignificantly higher physical
activity compared to PBS-injected ANKO females for the first half
of the 12 hr dark time (Figure 6B). Because the enhancement of
NAD+ biosynthesis by one NMN injection lasts for 6 hr in the
brain (Stein and Imai, 2014), this result provides support to our
notion that the hypothalami of ANKO females have defects in
NAD+ biosynthesis and its function. Because adipose tissue-
dependent eNAMPTsecretion is enhanced in response to fasting,
we also examined the physical activity levels of ANKO mice
after 48 hr fasting. Their physical activity levels in response
to fasting were significantly reduced compared to those of
control mice (Figure 6C). Contrarily, adipose tissue-specificfrom differentiated HIB-1B cells. The enzymatic activity was determined as
that of wild-type NAMPT (n = 2–6).
retion were calculated as described in Experimental Procedures. Each value is
dent experiments. Data were analyzed by Student’s t test or one-way ANOVA
% 0.05; ***p% 0.001.
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Figure 5. ANKOMice Exhibit Reduced Plasma eNAMPT Levels and Defects in NAD+ Biosynthesis Not Only in Adipose Tissue but Also in the
Hypothalamus
(A) iNAMPT levels in visceral white adipose tissue (WAT), subcutaneous WAT, brown adipose tissue (BAT), brain, liver, and muscle from 2-month-old female
Namptflox/flox (f/f) and ANKO mice.
(B) Tissue NAD+ levels in visceral WAT, subcutaneousWAT, BAT, liver, and skeletal muscle from 3- to 4-month-old femaleNamptflox/flox and ANKOmice (n = 4–8).
(C) Plasma eNAMPT levels in 5- to 6-month-old femaleNamptflox/flox and ANKOmice. Plasmawas collected frommice fed or fasted for 48 hr. Bottompanels show
average plasma eNAMPT levels normalized to those of Namptflox/flox mice (n = 8–10).
(D) Hypothalamic and hippocampal NAD+ levels in 3- to 4-month-old female Namptflox/flox and ANKO mice (n = 4–8).
(E) Relative Ox2r mRNA expression levels in the hypothalami and the hippocampi from 3- to 4-month-old female Namptflox/flox and ANKO mice (n = 4).
Data in (B)–(E) were analyzed by the Student’s t test. All values are presented as mean ± SEM. *p% 0.05; **p% 0.01; ***p% 0.001.Nampt knockin (ANKI) mice, which showed 2.2- to 2.5-fold
increases in plasma eNAMPT levels under fasting in both
males and females (Figure S4B), exhibited increases in physical
activity, compared to control mice, in response to fasting
(Figure 6D). Consistent with this phenotype, NAD+ levels were
significantly enhanced in ANKI hypothalami, but not in ANKI
hippocampi, compared to those in controls (Figure 6E). Ox2r
expression levels, which reflect hypothalamic SIRT1 activity,
were also enhanced in ANKI hypothalami (Figure 6F). Therefore,
these results provide significant support to our notion that
eNAMPT plays an important role in maintaining normal hypotha-
lamic NAD+ levels, SIRT1 activity, and physical activity, particu-
larly in response to fasting.712 Cell Metabolism 21, 706–717, May 5, 2015 ª2015 Elsevier Inc.A NAMPT-Neutralizing Antibody Reduces Hypothalamic
NAD+ Levels In Vivo, whereas eNAMPT Enhances
Hypothalamic NAD+ Biosynthesis, SIRT1 Activity, and
Neural Activity Ex Vivo
To further assess whether the NAD+ decrease observed in the
ANKO hypothalamus is the direct outcome of the decrease in
eNAMPT-mediated NAD+ production, we systemically injected a
NAMPT-neutralizing polyclonal antibody and control rabbit IgG
into wild-type B6 male mice. This particular polyclonal antibody
was able to suppress NAMPT enzymatic activity by 90% for re-
combinant NAMPT in vitro and by 40% for eNAMPT in plasma
(Figure S5). Interestingly, the injection of the NAMPT-neutralizing
antibody moderately but significantly reduced NAD+ levels in the
Figure 6. Physical Activity Is Altered in
Loss- and Gain-of-Function Mouse Models
of Adipose NAMPT
(A)Wheel-runningactivityofANKOandNamptflox/flox
female mice at 5 months of age (n = 3–6).
(B) Wheel-running activity of NMN-injected ANKO
female mice and PBS-injected ANKO and
Namptflox/flox female mice at 5 months of age
(n = 3–6). NMN was injected at 500 mg/kg body
weight at 5 p.m. (indicated by an arrow). Activity
counts per minute at each time point are shown as
mean values ± SEM.
(C) Physical activity levels (total numbers of
quadrants crossed) measured after 48 hr fasting
in ANKO and Namptflox/flox female mice at
4–5 months of age (n = 4).
(D) Physical activity levels (total numbers of
quadrants crossed) measured after 48 hr fasting
in ANKI and control male and female mice at
4–6 months of age (n = 4).
(E) Hypothalamic and hippocampal NAD+ levels in
8- to 10-month-old ANKI and control male mice
after 48 hr fasting (n = 5).
(F) Relative Ox2r mRNA expression levels in the
hypothalami from 8- to 10-month-old ANKI and
control male mice after 48 hr fasting (n = 5).
Data in (A) and (B) were analyzed by Wilcoxon
matched-pairs signed-ranks test. Data in (C)–(F)
were analyzed by Student’s t test. All values are
presented as mean ± SEM. *p% 0.05; **p% 0.01;
***p % 0.001.hypothalamus, but not in the hippocampus (Figure 7A), confirming
the direct effect of eNAMPT on hypothalamic NAD+ levels. To
further confirm the biological relevance of eNAMPT in the regula-
tion of hypothalamicNAD+ levels, we established an ex vivo assay
using hypothalamic explants. Using this assay, we examined the
direct effect of eNAMPT-containing conditioned media on NAD+
levels and neural activationmeasuredbycFosexpression in hypo-
thalamic explants. Interestingly, eNAMPT-containing conditioned
media were able to significantly increase NAD+ levels and cFos
expression in hypothalamic explants, compared to control condi-
tioned media (Figure 7B). The extent of cFos activation by
eNAMPT-containing conditioned media was similar to that by
ghrelin, an orexigenic gut hormone known to stimulate hypotha-
lamic neurons in rodents (Kobelt et al., 2008). Consistently, the
addition of the purified eNAMPT protein to culture media was
also able to significantly increase NAD+, cFos, and Ox2r levels in
hypothalamic explants (Figure 7C). These results provide further
support toournotion thateNAMPT iscapableofdirectlypromoting
hypothalamic NAD+ biosynthesis, SIRT1 activity, and neural acti-Cell Metabolism 21, 706vation. Taken together, our findings indi-
cate that NAD+/SIRT1-mediated eNAMPT
secretion from adipose tissue plays a crit-
ical role in the regulation of hypothalamic
NAD+ biosynthesis and function.
DISCUSSION
Our present study has demonstrated that
the secretion and enzymatic activity ofeNAMPT are regulated by SIRT1-dependent deacetylation in ad-
ipocytes. Indeed, this highly regulated process appears to be
important particularly in adipose tissue in response to changes
in nutritional availability. Interestingly, SIRT1 and NAMPT
comprise a novel transcriptional-enzymatic feedback loop that
produces a circadian oscillation of NAD+ in peripheral tissues
(Nakahata et al., 2009; Ramsey et al., 2009). Our present study
has revealed that SIRT1 and NAMPT comprise another NAD+-
regulatory feedback loop through the regulation of eNAMPT
secretion from adipose tissue. In this new mechanism, SIRT1-
dependent deacetylation of iNAMPT at K53 predisposes the pro-
tein to secretion. The deacetylation event seems to occur in the
cytoplasm of differentiated adipocytes, and approximately 0.5%
of iNAMPT per hour is estimated to be secreted as eNAMPT in
differentiated HIB-1B adipocytes (data not shown), suggesting
that a very specific fraction of iNAMPT is destined to enter this
SIRT1-dependent secretory machinery. The experiments with
K-to-R and K-to-Q mutants of K53 demonstrate that the acety-
lation status of K53 is critical to determine the fate of iNAMPT.–717, May 5, 2015 ª2015 Elsevier Inc. 713
Figure 7. eNAMPT Regulates Hypothalamic
NAD+ Levels, Ox2r Expression, and Neural
Activation
(A) NAD+ levels in the hypothalami and hippocampi
isolated fromB6male mice after systemic injection
of a NAMPT-neutralizing antibody. Twenty micro-
grams of anti-NAMPT antibody (NAMPT Ab) and
rabbit IgG (IgG) were injected into wild-type B6
male mice at 4–6 months of age. Hypothalamic
NAD+ levels 1 hr after injection were measured by
HPLC (n = 10–12).
(B) NAD+ levels (left) and cFos mRNA expression
(right) in hypothalamic explants treated with
eNAMPT-containing or control conditioned media.
Hypothalamic explants prepared from female mice
at 1–12 weeks of age were cultured in each
conditioned medium for 1 hr. For neural activity,
ghrelin (10 mg/ml) and PBS were also added to
eNAMPT-containing (+) or control () conditioned
media. NAD+ levels were measured by HPLC, and
cFos expression levels were quantitated by qRT-
PCR (n = 4–6).
(C) NAD+ levels and cFos and Ox2r mRNA
expression in adult hypothalamic explants cultured
in the media supplemented with the eNAMPT
protein purified from HEK293 culture supernatants
or bovine serum albumin (BSA) as a control for 3 hr
(n = 4–6). One microgram of each protein was
added to 50 ml of culture media containing a hy-
pothalamic explant. Data were analyzed by Stu-
dent’s t test or one-way ANOVA with Fisher’s LSD
post hoc test. All values are presented as mean ±
SEM. *p% 0.05; **p% 0.01.
(D) A model for the SIRT1-mediated regulation of
eNAMPT secretion in adipose tissue. iNAMPT
(a dimer in blue) is acetylated at K53 (Ac), and
SIRT1 specifically deacetylates this lysine, pre-
disposing the protein to secretion. Acetyl-K53
might provide a docking site to an unidentified
factor (red) that prevents NAMPT from secretion.
eNAMPT secreted from adipose tissue promotes
NAD+ biosynthesis, SIRT1 activity, and neural ac-
tivity in the hypothalamus.Because the K53A mutation also significantly increases
eNAMPT secretion, K53 appears to play an important role in
determining the fate of iNAMPT, possibly providing a docking
site to an unidentified factor that might interact with acetylated
K53 of iNAMPT and prevent it from secretion (Figure 7D).
Acetylation is also important to regulate the enzymatic activity
of NAMPT. We identified five acetylation sites on iNAMPT, and 4
out of these 5 sites are found to be deacetylated on eNAMPT. The
enzymatic activity of iNAMPT is 2- to 4-fold lower than that of
eNAMPT (Revollo et al., 2007), and the K53Qmutant can recapit-
ulate this acetylation-dependent reduction in the enzymatic ac-
tivity. K53 is distinguished from other lysine residues because
of its location at the ‘‘cleft,’’ which contains the catalytic sites,
although other lysinesmight have other functions in different bio-
logical contexts. These results indicate that acetylation/deacety-
lation might induce a conformational change in NAMPT structure
and regulate its enzymatic activity. It will be of great interest to
examine what effects the acetylation of K53 has on the structure
of the catalytic sites and dimer formation of NAMPT. Because714 Cell Metabolism 21, 706–717, May 5, 2015 ª2015 Elsevier Inc.NAD+ drives SIRT1 activity in a circadian oscillatory manner (Na-
kahata et al., 2009; Ramsey et al., 2009), it is also likely that de-
acetylation and secretion of eNAMPT follow circadian oscillation.
Indeed, plasma eNAMPT levels appear to show diurnal oscilla-
tion in mice, although it is still unclear whether this oscillation is
produced by an intrinsic clock mechanism (unpublished data).
Therefore, our findings provide an interesting possibility that
the intimate interplay between SIRT1 and NAMPT contributes
to multi-layered feedback loops regulating the dynamics of
NAD+ biosynthesis within and between tissues and organs.
Why does adipose tissue secrete a key NAD+ biosynthetic
enzyme to blood circulation? We have obtained important clues
to this question from adipose tissue-specific Nampt knockout
(ANKO) mice. Interestingly, ANKO females, but not males,
show significant decreases in plasma eNAMPT levels. A surpris-
ing finding is that the adipose tissue-specific deficiency of
NAMPT causes significant reduction in NAD+ levels not only in
WAT and BAT, but also in some remote tissues, specifically
the hypothalamus. Because the hypothalami of ANKO females
do not have any obvious defects in their endogenous NAD+
biosynthetic machineries, the observed reduction in NAD+ levels
is likely attributed to the NAMPT deficiency in adipose tissue.
Furthermore, the defect appears to be specific at least to the hy-
pothalamus, because other tissues and organs, including the
liver, skeletal muscle, and the hippocampus, do not show any
reduction in NAD+ levels. Consistent with reduced NAD+ levels,
ANKO female mice also show significant reduction in the
mRNA expression levels of Ox2r, a critical hypothalamic SIRT1
target gene, and their physical activity during the dark time.
This hypothalamic functional defect can be ameliorated, at least
partially, by a single injection of NMN. Additionally, the results
from the systemic injection of a NAMPT-neutralizing antibody
and ex vivo hypothalamic explant assays provide further support
for our conclusion that eNAMPT regulates hypothalamic NAD+
production and function. This role of eNAMPT in maintaining
normal hypothalamic NAD+ levels appears to be more important
in fasting because AT-Sirt1/ mice had a defect in fasting-
induced plasma eNAMPT increase and also showed further de-
creases in hypothalamic NAD+ levels, compared to controls, in
response to fasting. Consistent with this notion, loss- and gain-
of-function mouse models of adipose NAMPT, namely, ANKO
and ANKI mice, reciprocally change their plasma eNAMPT levels
and physical activity, as well as their hypothalamic NAD+ and
Ox2r expression levels, in response to fasting.
Although how exactly eNAMPT regulates hypothalamic NAD+
levels and neuronal activity is still under investigation, it is
conceivable that eNAMPT secreted from adipose tissue plays
a critical role in supplying NMN to the hypothalamus. The hypo-
thalamus has a low level of NAMPT expression, implying that this
tissue might require the extracellular supply of NMN, possibly
through the median eminence (Elmquist et al., 1999; Rodrı´guez
et al., 2010), for the maintenance of its optimal NAD+ biosyn-
thesis. Our finding that adipose tissue actively regulates the
secretion and enzymatic activity of eNAMPT in an NAD+/
SIRT1-dependent manner provides strong support to the idea
that adipose tissue functions as a critical determinant for
the spatial and temporal coordination of NAD+ biosynthesis
throughout the body. This systemic coordination of NAD+
biosynthesis might play an important role in orchestrating meta-
bolic responses in multiple tissues and maintaining metabolic
homeostasis against nutritional and environmental perturba-
tions. In this highly coordinated systemic network, adipose
tissuemodulates the functions of remote tissues, such as the hy-
pothalamus, through the NAD+/SIRT1-dependent regulation of
eNAMPT secretion. This model also predicts that having an
optimal amount of adipose tissue might be beneficial to maxi-
mize the robustness of the physiological system through the
regulation of systemic NAD+ biosynthesis. Further investigation
on the system dynamics of this novel network will provide insight
into the role of adipose tissue as a critical modulator for the regu-
lation of systemic NAD+ biosynthesis.EXPERIMENTAL PROCEDURES
Detection of Intracellular NAMPT and SIRT1 in Tissues and of
Extracellular NAMPT in Plasma
Mice fed ad libitum or fasted for 48 hr were euthanized by carbon dioxide
asphyxiation. Organs were immediately collected, homogenized in 1XCLaemmli sample buffer using a Polytron (Kinematica), and boiled for 5 min.
Samples were then centrifuged at 16,000 3 g, and protein concentrations
were measured by the Bradford assay (Bio-Rad). Plasma samples from mice
fed ad libitum or fasted for 48 hr were collected by centrifuging blood at
3,2003 g for 5min at 4C and immediately boiled for 5min in 1X Laemmli sam-
ple buffer. Tissue extracts and plasma samples were analyzed by western
blotting with anti-NAMPT (Bethyl Laboratories) or anti-SIRT1 (Sigma) anti-
bodies. For plasma samples, equal loading was confirmed by Ponceau S
staining of membranes.
Detection of Acetylated NAMPT in Adipose Tissue and
Differentiated HIB-1B Cells
WAT and BAT collected from wild-type FVB mice were homogenized in 1X
RIPA buffer (50 mM Tris-HCl [pH 8.0], 150 mM NaCl, 1% Igepal CA630, 0.5%
sodium deoxycholate, 0.1% SDS, 1 mM EDTA, 1 mM NaF, 10 mM Trichostatin
A, 10 mM nicotinamide, 0.5 mM DTT, protease inhibitor cocktail [Roche]). Tis-
sue extracts were immunoprecipitated with anti-acetyl lysine antibody-conju-
gated beads (ImmuneChem) overnight. Immunoprecipitates were eluted with
1X Laemmli sample buffer, boiled for 5 min, and analyzed by western blotting
with an anti-NAMPT antibody (OMNI379, Enzo Life Science). Fully differenti-
ated HIB-1B cells were homogenized in NAMPT-IP buffer (PBS [pH 7.4],
0.5% NP-40, 1 mM EDTA, 1 mM NaF, 10 mM trichostatin A, 10 mM nicotin-
amide, 0.5 mM DTT, protease inhibitor cocktail [Roche]), and cell extracts
were immunoprecipitated with an anti-acetyl lysine antibody (Cell Signaling)
or an anti-NAMPT antibody (Bethyl Laboratories) and protein A agarose
(Sigma). NAMPT was detected by western blotting with the same anti-NAMPT
antibody and light-chain anti-rabbit IgG (Jackson ImmunoResearch).
Generation of HIB-1B Cells Stably Expressing Wild-Type or Mutant
NAMPT-FLAG
A C-terminally FLAG-tagged NAMPT (NAMPT-FLAG) was created and cloned
into the mammalian expression vector pCXN2 as described previously (Re-
vollo et al., 2007). Each lysine mutant NAMPT-FLAG was generated using
the QuikChange II Site-Directed Mutagenesis Kit (Stratagene) according to
the manufacturer’s protocol. To create HIB-1B cells expressing NAMPT-
FLAG or mutant NAMPT-FLAG, HIB-1B pre-adipocytes were transfected
(Superfect, QIAGEN) with pCXN2-NAMPT-FLAG or pCXN2 mutant NAMPT-
FLAG. Transfected HIB-1B cells were selected by incubating with 500 mg/ml
of G418 (Invitrogen) for 2 weeks. Before the secretion assay and the enzymatic
reactions, HIB-1B cells were fully differentiated as described above.
eNAMPT Secretion Assay
3T3-L1 or HIB-1B cells were differentiated as described above. To detect
endogenous iNAMPT or eNAMPT, cell extracts or culture supernatant were
collected, respectively, immunoprecipitated as described previously (Revollo
et al., 2007), and analyzed by western blotting with an anti-NAMPT polyclonal
antibody (Bethyl Laboratories). HEK293 cells transfected with NAMPT-FLAG
and HIB-1B cells stably expressing NAMPT-FLAG were processed in the
same way, except that anti-FLAG beads (M2, Sigma) were used for immuno-
precipitation. eNAMPT secretion levels were calculated as (eNAMPT levels/
iNAMPT levels)/the amount of total protein in cell lysates or eNAMPT levels/
(iNAMPT levels/ACTIN levels)/the amount of total protein in cell lysates by
quantifying western blotting results.
Enzymatic Reactions
NAMPT enzymatic reactions were conducted as previously described (Revollo
et al., 2007). For immunoprecipitation of iNAMPT-FLAG, whole-cell extracts
were prepared with NAMPT-IP buffer and mixed with anti-FLAG-M2-
conjugated beads (Sigma) for 2–3 hr at 4C. For immunoprecipitation of
eNAMPT-FLAG, HIB-1B culture supernatants were collected after incubating
differentiated HIB-1B cells overnight with DMEM without fetal bovine
serum but supplemented with 5 mg/ml insulin and 1 nM triiodothyronine,
centrifuged at 3,000 rpm for 2 min at 4C, concentrated 8- to 10-fold with
Amicon Ultra-15 columns (Millipore), and mixed with anti-FLAG beads for
2–3 hr at 4C. Immunoprecipitates were washed twice with IP buffer and twice
with PBS.
Immunoprecipitates on anti-FLAG beads were incubated in enzymatic reac-
tion buffer (50 mM Tris-HCl [pH 8.5], 100 mM NaCl, 0.25 mM nicotinamide,ell Metabolism 21, 706–717, May 5, 2015 ª2015 Elsevier Inc. 715
10 mM MgSO4, 1.5% ethanol, 0.5 mM phosphoribosyl phyrophosphate
[PRPP], 2 mM ATP) for 55 min at 37C. After this reaction, mouse recombinant
NMNAT and yeast alcohol dehydrogenase were added at a final concentration
of 10 mg/ml each, and the mixture was incubated for 5 min at 37C. Superna-
tants were collected by spinning down anti-FLAG beads, and auto-fluores-
cence of NADH was measured in a PerkinElmer LS 50B fluorometer (340 nm
excitation, 460 nm emission). NADH auto-fluorescence values were converted
to the amount of NMN using a standard curve drawn with known amounts of
NMN. Immunoprecipitates bound on anti-FLAG beads were extracted with
1X Laemmli buffer, boiled for 5 min, and analyzed by western blotting with
an anti-NAMPT antibody. The amounts of NAMPT used for enzymatic reac-
tions were quantitated compared to the standards of mouse recombinant
NAMPT. Kcat values were calculated based on the molar amount of NMN
generated per molar amount of immunoprecipitated NAMPT-FLAG proteins
per unit time.
Generation of AT-Sirt1–/–, ANKO, and ANKI Mice and Measurement
of Their Physical Activity Levels
Sirt1flox/flox mice were generated by flanking exon 3 of the Sirt1 gene by loxP
sites. Namptflox/flox mice, Cre-inducible STOP-Nampt mice, and adiponectin-
Cre mice were generously provided by Dr. Oberdan Leo at Universite´ de Le´ige,
Belgium (Rongvaux et al., 2008), Dr. Joseph Baur at University of Pennsylvania
(Frederick et al., 2015), and Dr. Evan Rosen at Beth Israel Deaconess Medical
Center (Eguchi et al., 2011), respectively. All lines were backcrossed to the
C57BL/6J background. Adiponectin-Cre mice were mated with Sirt1flox/flox,
Namptflox/flox, or STOP-Nampt mice, and cohorts were established by mating
F1Sirt1flox/+;Cre orNamptflox/+;Cre toSirt1flox/flox orNamptflox/floxmice, respec-
tively. Sirt1flox/flox;Cre and Namptflox/flox;Cre were considered as AT-Sirt1/
and ANKO mice, respectively. Sirt1flox/flox;+ and Namptflox/flox;+ were used as
controls. For ANKI mice, Cre-induced heterozygous mice were used, and
Cre-minus littermates were used as controls. When necessary, synchronized
females were used. For synchronization of female estrus cycle, female mice
were exposed to bedding from male cages for 3 days. Wheel-running activity
of mice was recorded and evaluated as described previously (Satoh et al.,
2010). Physical activity after 48 hr fasting was measured by counting the
numbers of quadrants crossed during 10 min in recorded videos of each
cage containing five mice (Satoh et al., 2010). All animal procedures were
approved by the Washington University Animal Studies Committee and were
in accordance with NIH guidelines.
In Vivo eNAMPT Neutralization
Twentymicrograms of anti-NAMPT rabbit antibody (Bethyl Laboratory) or con-
trol rabbit IgG (Sigma) was diluted in 100 ml PBS. One hundred microliters of
the solution was injected to 3- to 4-week-old age-matched male mice intrave-
nously via tail vein. One hour after injection, injected mice were sacrificed and
hypothalamus was collected. Hypothalamic samples were stored frozen until
analysis.
Ex Vivo Hypothalamic Explant Culture
Hypothalami were collected from 1- to 12-week-old mice and cut into hemihy-
pothalami along the sagittal plane. Biologically matched hemihypothalami
were incubated with either eNAMPT-containing or control conditioned media
for 1 hr at 37C. In separate experiments, hemihypothalami were incubated
with serum-free media (50 ml) supplemented with 1 mg of either the eNAMPT
protein purified from HEK293 culture supernatants (Adipogen) or BSA for
3 hr at 37C. Hypothalamic samples were stored frozen until analysis. Quanti-
tative real-time RT-PCR was conducted with the TaqMan Fast Universal PCR
Master mix and TaqMan primers for cFos and Gapdh in the GeneAmp 7500
fast sequence detection system (Applied Biosystems). Relative gene expres-
sion levels were calculated by normalizing to Gapdh levels and then to the
mean of control hypothalamic explants.
Statistical Analysis
Differences between two groups were assessed using the Student’s t test.
Comparisons among several groups were performed using one-way ANOVA
with the Fisher’s LSD post hoc test. p values equal to or less than 0.05 were
considered statistically significant. All values were presented as mean ± stan-
dard error of the mean (SEM).716 Cell Metabolism 21, 706–717, May 5, 2015 ª2015 Elsevier Inc.SUPPLEMENTAL INFORMATION
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